According to China Dasheng Biotechnology latest financial reports the cash on hand of CDBT is $125.69K, an increase of Infinity% to 2022. At the end of 2022 company had $0 cash on hand. This amount reflects the liquid assets available to the company, which are crucial for its operational flexibility, investment opportunities, and overall financial security.
Year | Cash on Hand | Change |
---|---|---|
2023 | $125.69K | Infinity% |
2022 | $0 | - |